Showing 3331-3340 of 5346 results for "".
Icotrokinra and the Oral Therapy Revolution
https://practicaldermatology.com/topics/psoriasis/icotrokinra-and-the-oral-therapy-revolution/60986/Icotrokinra is the only commercially available therapy that selectively blocks the receptor of IL-23 rather than the IL-23 cytokine.Navigating the Latest Therapeutic Options
https://practicaldermatology.com/issues/october-2025/navigating-the-latest-therapeutic-options/39762/A Q&A With Raj Chovatiya, MD, PhD, MSCI, FAADFrom SDPA: JAKs, Black Boxes, and What It All Means
https://practicaldermatology.com/conferences/sdpa-2024/sdpa-jaks-black-boxes-and-what-it-all-means/26286/Practitioners shouldn’t fear Janus kinase (JAK) inhibitors for their patients when appropriate, according to a wide-ranging expert chat at the 2024 SDPA Annual Summer Conference in San Diego. The conversation featured Matthew Zirwas, MD, a dermatologist with DOCS Dermatology, and Amy Spizuoco, DO, FClinical Conversations Video with Dr Scott Boswell
https://practicaldermatology.com/videos/nemluvio-peer-network/clinical-conversations-video-with-dr-scott-boswell/56420/Join Dr Scott Boswell as he shares how he approaches prurigo nodularis (PN) and atopic dermatitis (AD) in his expansive dermatology practice. From his 3‑step communication framework to compelling patient stories, Dr Boswell emphasizes how prioritizing safety and understanding neuroimmune mechanismsPrioritizing Patient Comfort While Optimizing Staff Safety
https://practicaldermatology.com/columns/practice-management-essentials/prioritizing-patient-comfort-while-optimizing-staff-safety/67264/While well-intentioned, hand holding may not be practical during an ongoing procedure and could pose ergonomic concerns for the clinical team.Harnessing Psychology to Make Your Practice and Outside Life Better
https://practicaldermatology.com/topics/editorial/harnessing-psychology-make-your-practice-and-outside-life-better/26952/Harnessing Psychology to Make Your Practice and Outside Life BetterSelecting the Optimal JAK Inhibitor for Alopecia Areata
https://practicaldermatology.com/topics/hair-nails/selecting-the-optimal-jak-inhibitor-for-alopecia-areata/67265/Since 2022, the US Food and Drug Administration (FDA) has approved three oral JAK inhibitors: baricitinib, ritlecitinib, and deuruxolitinib.Best Practices for Photodynamic Therapy for Actinic Keratosis
https://practicaldermatology.com/columns/skin-cancer-essentials/best-practices-for-photodynamic-therapy-for-actinic-keratosis/67261/Photodynamic therapy (PDT) remains an effective field-directed treatment for actinic keratoses (AKs)Apocrine Hidrocystoma of the Axilla
https://practicaldermatology.com/issues/october-2025/apocrine-hidrocystoma-of-the-axilla-an-illustrative-case-and-literature-review/39757/An Illustrative Case and Literature ReviewAntioxidants and Skin Cancer Risk: A Look at Vitamins A and B
https://practicaldermatology.com/topics/skin-cancer-photoprotection/antioxidants-and-skin-cancer-risk-a-look-at-vitamins-a-and-b/23106/There is some evidence to suggest that higher intake of these antioxidants may reduce skin cancer risks.